Active, not recruitingNCT06172374

A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials

Studying Primary ciliary dyskinesia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ReCode Therapeutics
Principal Investigator
John G. Matthews, MBBS, MRCP, PhD
ReCode Therapeutics, Inc.
Intervention
Sano Genetics Testing Kit(genetic)
Enrollment
150 enrolled
Eligibility
18 years · All sexes
Timeline
20232025

Study locations (1)

Collaborators

Sano Genetics · Reverba

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06172374 on ClinicalTrials.gov

Other trials for Primary ciliary dyskinesia

Additional recruiting or active studies for the same condition.

See all trials for Primary ciliary dyskinesia

← Back to all trials